Log In
Print this Print this

AMG 729

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionHumanized mAb targeting CD19 and Fc gamma receptor IIb (CD32B) (FCGR2B)
Molecular Target CD19 ; Fc gamma receptor IIb (FCGR2B) (CD32B)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today